Literature DB >> 16703417

IL-20: biological functions and clinical implications.

Chi-Chen Wei1, Yu-Hsiang Hsu, Hsing-Hui Li, Yo-Ching Wang, Mei-Yi Hsieh, Wei-Yu Chen, Chung-Hsi Hsing, Ming-Shi Chang.   

Abstract

IL-20 belongs to the IL-10 family and plays a role in skin inflammation and the development of hematopoietic cells. Little is known about its other biological functions and clinical implications, however. Updated information about IL-20, such as its identification, expression, receptors, signaling, biological activities, and potential clinical implications, is illustrated in this review based on our research and on data available in the literature. Our studies of IL-20 show that it is a pleiotropic cytokine with potent inflammatory, angiogenic, and chemoattractive characteristics. Inflammation and angiogenesis are essential for the pathogenesis of rheumatoid arthritis and atherosclerosis. Based on in vitro data and clinical samples, we demonstrated that IL-20 is involved in the diseases of rheumatoid arthritis and atherosclerosis. In addition, we found in our studies that IL-20 signaled through different molecules in several cells. The present review presents the clinical implications of IL-20 in rheumatoid arthritis and atherosclerosis. It may provide new therapeutic options in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703417     DOI: 10.1007/s11373-006-9087-5

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  27 in total

1.  A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium.

Authors:  Anne B Newman; Stefan Walter; Kathryn L Lunetta; Melissa E Garcia; P Eline Slagboom; Kaare Christensen; Alice M Arnold; Thor Aspelund; Yurii S Aulchenko; Emelia J Benjamin; Lene Christiansen; Ralph B D'Agostino; Annette L Fitzpatrick; Nora Franceschini; Nicole L Glazer; Vilmundur Gudnason; Albert Hofman; Robert Kaplan; David Karasik; Margaret Kelly-Hayes; Douglas P Kiel; Lenore J Launer; Kristin D Marciante; Joseph M Massaro; Iva Miljkovic; Michael A Nalls; Dena Hernandez; Bruce M Psaty; Fernando Rivadeneira; Jerome Rotter; Sudha Seshadri; Albert V Smith; Kent D Taylor; Henning Tiemeier; Hae-Won Uh; André G Uitterlinden; James W Vaupel; Jeremy Walston; Rudi G J Westendorp; Tamara B Harris; Thomas Lumley; Cornelia M van Duijn; Joanne M Murabito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-18       Impact factor: 6.053

2.  Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.

Authors:  M G Alexandrakis; C A Pappa; M Kokonozaki; A Boula; R Vyzoukaki; D Staphylaki; A Papadopoulou; N Androulakis; G Tsirakis; A Sfiridaki
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

Review 3.  IL-20 receptor cytokines in autoimmune diseases.

Authors:  Jun Chen; Rachel R Caspi; Wai Po Chong
Journal:  J Leukoc Biol       Date:  2018-09-07       Impact factor: 4.962

4.  Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.

Authors:  Jie Meng; Dong-liang Wang; Paul C Wang; Lee Jia; Chunying Chen; Xing-Jie Liang
Journal:  J Nanosci Nanotechnol       Date:  2010-12

5.  A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155.

Authors:  Bushra Husain; Sree R Ramani; Eugene Chiang; Isabelle Lehoux; Sairupa Paduchuri; Tia A Arena; Ashka Patel; Blair Wilson; Pamela Chan; Yvonne Franke; Athena W Wong; Jennie R Lill; Shannon J Turley; Lino C Gonzalez; Jane L Grogan; Nadia Martinez-Martin
Journal:  Mol Cell Proteomics       Date:  2019-07-15       Impact factor: 5.911

6.  IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation.

Authors:  Yu-Hsiang Hsu; Chih-Hsing Wu; Chiao-Juno Chiu; Wei-Ting Chen; Yi-Chieh Chang; Martin Wabitsch; Ming-Shi Chang
Journal:  Immunology       Date:  2021-08-30       Impact factor: 7.397

7.  IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs.

Authors:  Katerina Tritsaris; Maja Myren; Sisse B Ditlev; Martin V Hübschmann; Ida van der Blom; Anker Jon Hansen; Uffe B Olsen; Renhai Cao; Junhang Zhang; Tanghong Jia; Eric Wahlberg; Steen Dissing; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 8.  Psoriasis and metabolic disease: epidemiology and pathophysiology.

Authors:  Rahat S Azfar; Joel M Gelfand
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

9.  Anti-IL-20 monoclonal antibody suppresses hepatocellular carcinoma progression.

Authors:  Wen-Zhou Ding; Guo-Yong Han; Hui-Han Jin; Chuan-Fei Zhan; Yuan Ji; Xin-Li Huang
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

10.  Reduction of IL-20 Expression in Rheumatoid Arthritis by Linear Polarized Infrared Light Irradiation.

Authors:  Asayo Imaoka; Lin Zhang; Noboru Kuboyama; Yoshimitsu Abiko
Journal:  Laser Ther       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.